112 related articles for article (PubMed ID: 9620304)
1. The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE.
Porter RM; Reichelt J; Lunny DP; Magin TM; Lane EB
J Invest Dermatol; 1998 Jun; 110(6):951-7. PubMed ID: 9620304
[TBL] [Abstract][Full Text] [Related]
2. Hyperproliferation, induction of c-Myc and 14-3-3sigma, but no cell fragility in keratin-10-null mice.
Reichelt J; Magin TM
J Cell Sci; 2002 Jul; 115(Pt 13):2639-50. PubMed ID: 12077355
[TBL] [Abstract][Full Text] [Related]
3. Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis.
Porter RM; Leitgeb S; Melton DW; Swensson O; Eady RA; Magin TM
J Cell Biol; 1996 Mar; 132(5):925-36. PubMed ID: 8603923
[TBL] [Abstract][Full Text] [Related]
4. A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis.
Bickenbach JR; Longley MA; Bundman DS; Dominey AM; Bowden PE; Rothnagel JA; Roop DR
Differentiation; 1996 Dec; 61(2):129-39. PubMed ID: 8983179
[TBL] [Abstract][Full Text] [Related]
5. Out of balance: consequences of a partial keratin 10 knockout.
Reichelt J; Bauer C; Porter R; Lane E; Magin V
J Cell Sci; 1997 Sep; 110 ( Pt 18)():2175-86. PubMed ID: 9378767
[TBL] [Abstract][Full Text] [Related]
6. Human epidermal basal cell responses to ultraviolet-B differ according to their location in the undulating epidermis.
Baba H; Yoshida M; Yokota T; Uchiwa H; Watanabe S
J Dermatol Sci; 2005 Apr; 38(1):41-6. PubMed ID: 15795122
[TBL] [Abstract][Full Text] [Related]
7. Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles.
Xie W; Wu X; Chow LT; Chin E; Paterson AJ; Kudlow JE
Cell Growth Differ; 1998 Apr; 9(4):313-25. PubMed ID: 9563851
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic heterogeneity in bullous congenital ichthyosiform erythroderma: possible somatic mosaicism for keratin gene mutation in the mildly affected mother of the proband.
Nomura K; Umeki K; Hatayama I; Kuronuma T
Arch Dermatol; 2001 Sep; 137(9):1192-5. PubMed ID: 11559215
[TBL] [Abstract][Full Text] [Related]
9. Expression of keratins K6 and K16 in regenerating mouse epidermis is less restricted by cell replication than the expression of K1 and K10.
Heyden A; Lützow-Holm C; Clausen OP; Brandtzaeg P; Huitfeldt HS
Epithelial Cell Biol; 1994 Jul; 3(3):96-101. PubMed ID: 7534576
[TBL] [Abstract][Full Text] [Related]
10. How do keratinizing disorders and blistering disorders overlap?
Hamada T; Tsuruta D; Fukuda S; Ishii N; Teye K; Numata S; Dainichi T; Karashima T; Ohata C; Furumura M; Hashimoto T
Exp Dermatol; 2013 Feb; 22(2):83-7. PubMed ID: 23039137
[TBL] [Abstract][Full Text] [Related]
11. [Bullous congenital ichthyosiform erythroderma of Brocq; 2 patients with different phenotype and genotype].
Lavrijsen AP; Bergman W; Steijlen PM
Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1527-8. PubMed ID: 11569466
[No Abstract] [Full Text] [Related]
12. An atypical form of bullous congenital ichthyosiform erythroderma is caused by a mutation in the L12 linker region of keratin 1.
Kremer H; Lavrijsen AP; McLean WH; Lane EB; Melchers D; Ruiter DJ; Mariman EC; Steijlen PM
J Invest Dermatol; 1998 Dec; 111(6):1224-6. PubMed ID: 9856846
[TBL] [Abstract][Full Text] [Related]
13. A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis.
Müller FB; Huber M; Kinaciyan T; Hausser I; Schaffrath C; Krieg T; Hohl D; Korge BP; Arin MJ
Hum Mol Genet; 2006 Apr; 15(7):1133-41. PubMed ID: 16505000
[TBL] [Abstract][Full Text] [Related]
14. A keratin K10 gene mutation in a Japanese patient with epidermolytic hyperkeratosis.
Nomura K; Meng X; Umeki K; Tamai K; Sawamura D; Hashimoto I; Kikuchi T
Jpn J Hum Genet; 1997 Mar; 42(1):217-23. PubMed ID: 9184002
[TBL] [Abstract][Full Text] [Related]
15. Loss of keratin K2 expression causes aberrant aggregation of K10, hyperkeratosis, and inflammation.
Fischer H; Langbein L; Reichelt J; Praetzel-Wunder S; Buchberger M; Ghannadan M; Tschachler E; Eckhart L
J Invest Dermatol; 2014 Oct; 134(10):2579-2588. PubMed ID: 24751727
[TBL] [Abstract][Full Text] [Related]
16. Mild recessive bullous congenital ichthyosiform erythroderma due to a previously unidentified homozygous keratin 10 nonsense mutation.
Tsubota A; Akiyama M; Kanitakis J; Sakai K; Nomura T; Claudy A; Shimizu H
J Invest Dermatol; 2008 Jul; 128(7):1648-52. PubMed ID: 18219278
[TBL] [Abstract][Full Text] [Related]
17. Specific alterations in keratin biosynthesis in mouse epidermis in vivo and in explant culture following a single exposure to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
Molloy CJ; Laskin JD
Cancer Res; 1987 Sep; 47(17):4674-80. PubMed ID: 2441853
[TBL] [Abstract][Full Text] [Related]
18. Epidermolytic hyperkeratosis.
Bale SJ; Compton JG; DiGiovanna JJ
Semin Dermatol; 1993 Sep; 12(3):202-9. PubMed ID: 7692917
[TBL] [Abstract][Full Text] [Related]
19. Epidermolytic acanthomas: clinical characteristics and immunohistochemical features.
Cohen PR; Ulmer R; Theriault A; Leigh IM; Duvic M
Am J Dermatopathol; 1997 Jun; 19(3):232-41. PubMed ID: 9185908
[TBL] [Abstract][Full Text] [Related]
20. Focal activation of a mutant allele defines the role of stem cells in mosaic skin disorders.
Arin MJ; Longley MA; Wang XJ; Roop DR
J Cell Biol; 2001 Feb; 152(3):645-9. PubMed ID: 11157989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
